PMC:7572507 / 17597-18278 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7572507","sourcedb":"PMC","sourceid":"7572507","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7572507","text":"So far, only one registry-based study has evaluated patients with PC with SARS-CoV-2 infection [9]. It found 118 cases of patients with PC with laboratory-confirmed SARS-CoV-2 infection attending 68 hospitals in Italy's Veneto region and, by matching these cases to the Regional Cancer Registry data, the authors showed that only four of 5273 patients with PC receiving ADT (0.07%) developed the infection. As these patients were at significantly lower risk of developing SARS-CoV-2 infection than the patients who did not receive ADT or who had other types of cancer, the authors concluded that ADT may reduce sensitivity to the virus. Furthermore, none of the four patients died.","tracks":[{"project":"2_test","denotations":[{"id":"33091718-32387456-28903274","span":{"begin":96,"end":97},"obj":"32387456"}],"attributes":[{"subj":"33091718-32387456-28903274","pred":"source","obj":"2_test"}]},{"project":"MyTest","denotations":[{"id":"33091718-32387456-28903274","span":{"begin":96,"end":97},"obj":"32387456"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"attributes":[{"subj":"33091718-32387456-28903274","pred":"source","obj":"MyTest"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#deec93","default":true},{"id":"MyTest","color":"#e093ec"}]}]}}